Glenmark Pharmaceuticals Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹3,900.62 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 35.49 per cent from ₹6,046.87 crore. This corresponds to a year-on-year *(YoY) growth of 15.15 per cent.
Operating Profit
Operating Profit stands at ₹85.90 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 67.84 per cent from ₹267.09 crore. This corresponds to a year-on-year *(YoY) growth of 2.97 per cent.
PBDT
PBDT stands at ₹285.22 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 42.75 per cent from ₹498.17 crore. This corresponds to a year-on-year *(YoY) growth of 23.46 per cent.
Profit Before Tax
Profit Before Tax stands at ₹534.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 44.80 per cent from ₹967.40 crore. This corresponds to a year-on-year *(YoY) growth of 17.02 per cent.
Net Profit
Net Profit stands at ₹587.55 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 70.56 per cent from ₹1,995.47 crore. This represents a 68.86 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Glenmark Pharmaceuticals Ltd News
Glenmark Pharmaceuticals Ltd Earnings
- YOY
- QOQ
Glenmark Pharmaceuticals Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Glenmark Pharmaceuticals Ltd Research Reports
Glenmark Pharmaceuticals Ltd Financial Reports
Glenmark Pharmaceuticals Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Glenmark Pharma. | -1.91% | -0.51% | -7.16% | 5.28% | -4.41% | 27.45% |
| Alkem Lab | 0.20% | 1.87% | -2.30% | -0.28% | 18.89% | 17.97% |
| Biocon | -0.68% | -0.91% | -3.37% | -4.46% | 6.36% | -3.18% |
| Abbott India | 0.57% | 0.41% | -3.23% | -7.05% | -16.47% | -7.57% |
| Laurus Labs | -1.48% | 2.67% | -13.65% | -5.08% | 15.77% | 51.97% |
| Glaxosmi. Pharma | 2.47% | 3.25% | 3.63% | -2.14% | -6.14% | 16.08% |
| Anthem Bioscienc | 3.00% | 11.36% | 1.32% | -7.34% | -10.53% | -10.55% |
Company Info
Company Information
Chairman / Executive Director / M D / Promoter : Glenn Saldanha
ED / WTD / Promoter : Cheryl Pinto
ED / President / Global CFO : Anurag Mantri
Non Executive Director : B E Saldanha
Independent Non Exe. Director : Sona Saira Ramasastry
Independent Non Exe. Director : Dipankar Bhattacharjee
Independent Non Exe. Director : V R Iyer
Independent Non Exe. Director : Pradeep Kumar Sinha
Company Sec. & Compli. Officer : Harish Kuber